Protects patient access to clinician-administered medications by prohibiting certain practices by health insurance issuers.

West Virginia HB5482 aims to safeguard patient access to clinician-administered medications by restricting certain actions by health insurance issuers. The bill prohibits insurers from interfering with patients' choices to obtain these drugs from their preferred provider or pharmacy, including any inducements, steering, or incentives. It also bans insurers from requiring these drugs to meet specific quality measures or from denying coverage based on the location of administration.

Protects patient access to clinician-administered medications by prohibiting certain practices by health insurance issuers.

West Virginia HB5482 aims to safeguard patient access to clinician-administered medications by restricting certain actions by health insurance issuers. The bill prohibits insurers from interfering with patients' choices to obtain these drugs from their preferred provider or pharmacy, including any inducements, steering, or incentives. It also bans insurers from requiring these drugs to meet specific quality measures or from denying coverage based on the location of administration.